Author response: Evaluating the safety of {beta}-interferons in MS: A series of nested case-control studies

I thank Dr. Jongen for the interest in our article,1 and agree with the points made. While space precluded us from citing all the relevant literature in the main text of our article, interested readers can access an extensive review, including the article by Jongen et al.,2 as an appendix to our article (appendix e-1).1 The appendix includes over 100 studies and case reports related to potential adverse effects of the β-interferons and outlines the article referred to by Dr. Jongen.2
Source: Neurology - Category: Neurology Authors: Tags: WRITECLICK & amp;reg; EDITOR ' S CHOICE Source Type: research